Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia
- PMID: 20404980
- PMCID: PMC2854640
- DOI: 10.3747/co.v17i2.453
Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia
Abstract
Febrile neutropenia is a well-known entity in children with cancer, being responsible for the high risk for infection that characterizes this population. For this reason, cancer patients are hospitalized so that they can receive prophylactic care. Risk factors have been used to classify patients at a high risk for developing bacteremia. The present study evaluates whether those risk factors (C-reactive protein, hypotension, leukemia as the cancer type, thrombocytopenia, recent chemotherapy, and acute malnutrition) apply to patients at the Unidad Nacional de Oncología Pediátrica. We evaluated 102 episodes in 88 patients, in whom risk factors and blood cultures were tested. We observed no statistical relationship between the six risk factors and bacteremia. There was also no relationship between bacteremia and the simultaneous presence of two, three, or more risk factors. A significant relationship of C-reactive protein and platelet count with other outcome factors was observed.
Keywords: C-reactive protein; Cancer; bacteremia; fever; leukemia; neutropenia; risk factors; thrombocytopenia.
Similar articles
-
The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.Cancer. 1996 Feb 15;77(4):791-8. Cancer. 1996. PMID: 8616774
-
Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia.Cancer. 2001 Aug 15;92(4):909-13. doi: 10.1002/1097-0142(20010815)92:4<909::aid-cncr1400>3.0.co;2-h. Cancer. 2001. PMID: 11550165
-
The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.J Pediatr Hematol Oncol. 2007 Mar;29(3):131-6. doi: 10.1097/MPH.0b013e3180308770. J Pediatr Hematol Oncol. 2007. PMID: 17356388 Clinical Trial.
-
[Prevention and treatment of febrile neutropenia].Tumori. 1997;83(2 Suppl):S15-9. Tumori. 1997. PMID: 9235724 Review. Italian.
-
Risk Factors.In: The National Association of Medical Examiners’ Panel on Sudden Unexpected Death in Pediatrics; Bundock EA, Corey TS, Andrew TA, Crandall LG, Eason EA, Gunther WM, Moon RY, Palusci VJ, Schmidt CM, Sens MA, editors. Unexplained Pediatric Deaths: Investigation, Certification, and Family Needs [Internet]. San Diego (CA): Academic Forensic Pathology International; 2019. Chapter 3. In: The National Association of Medical Examiners’ Panel on Sudden Unexpected Death in Pediatrics; Bundock EA, Corey TS, Andrew TA, Crandall LG, Eason EA, Gunther WM, Moon RY, Palusci VJ, Schmidt CM, Sens MA, editors. Unexplained Pediatric Deaths: Investigation, Certification, and Family Needs [Internet]. San Diego (CA): Academic Forensic Pathology International; 2019. Chapter 3. PMID: 35107927 Free Books & Documents. Review. No abstract available.
Cited by
-
Clinical Epidemiology Characteristics and Etiology of Febrile Neutropenia in Children: Analysis of 421 Cases.Hematol Rep. 2022 Aug 1;14(3):245-252. doi: 10.3390/hematolrep14030034. Hematol Rep. 2022. PMID: 35997401 Free PMC article.
-
Etiology and Factors Affecting Severe Complications and Mortality of Febrile Neutropenia in Children with Acute Leukemia.Turk J Haematol. 2023 Aug 31;40(3):143-153. doi: 10.4274/tjh.galenos.2023.2023.0185. Epub 2023 Aug 1. Turk J Haematol. 2023. PMID: 37525503 Free PMC article.
-
Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy.Infect Drug Resist. 2014 Nov 6;7:289-99. doi: 10.2147/IDR.S70486. eCollection 2014. Infect Drug Resist. 2014. PMID: 25395866 Free PMC article.
-
Does age play a role in fever and neutropenia events and complications: A comparison of adolescents versus younger children with cancer at a tertiary care pediatric hospital, a pilot project.Cancer Rep (Hoboken). 2023 Apr;6(4):e1767. doi: 10.1002/cnr2.1767. Epub 2022 Dec 9. Cancer Rep (Hoboken). 2023. PMID: 36494902 Free PMC article. Review.
-
Risk factors for bacteremia in children with febrile neutropenia.Turk J Med Sci. 2019 Aug 8;49(4):1198-1205. doi: 10.3906/sag-1901-90. Turk J Med Sci. 2019. PMID: 31385488 Free PMC article.
References
-
- Tamburro R. Pediatric cancer patients in clinical trials of sepsis: factors that predispose to sepsis and stratify outcome. Pediatr Crit Care Med. 2005;6(suppl):S87–91. - PubMed
-
- Pizzo PA. Fever in immunocompromised patients. N Engl J Med. 1999;341:893–900. - PubMed
-
- Allen UD. Factors influencing predisposition to sepsis in children with cancers and acquired immunodeficiencies unrelated to human immunodeficiency virus infection. Pediatr Crit Care Med. 2005;6(suppl):S80–6. - PubMed
-
- Santolaya ME, Alvarez AM, Becker A. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol. 2001;19:3415–21. - PubMed
-
- Castagnola E, Viscoli C, Bernaola E. Complicaciones infecciosas en el niño con enfermedad hematooncológica. In: Sierrasesúmaga L, Antillón Klussmann F, editors. Tratado de Oncología Pediátrica. Madrid: Pearson Educación S.A; 2006. pp. 755–84.
LinkOut - more resources
Full Text Sources
Research Materials